Drug Trial Radar · NCT06116045
Evaluation of the Efficacy, Safety and Tolerability of BZ371A in Women with Sexual Arousal Disorder
Last checked: Nov 19, 2026Latest source record: Oct 22, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
30
Planned (sponsor's estimate)
Start
Oct 1, 2024
Primary completion
Feb 1, 2025
Study completion Mar 31, 2025
Sponsor
- Lead sponsor
- Biozeus Biopharmaceutical S.A.Industry
- Sponsor type
- Industry
- First posted
- Nov 3, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Female only, from 21 years, up to 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To determine the efficacy in increasing sexual arousal, safety and tolerability of BZ371A in gel form applied to women with sexual arousal disorder.
Conditions
- Female Sexual Arousal Disorder
- Female Sexual Dysfunction
Interventions
BZ371A 7.5 mg (1.5 ml)Drug
7.5 mg gel
BZ371A 5.0 mg (1.0 ml)Drug
5.0 mg gel
BZ371A 2.5 mg (0.5 ml)Drug
2.5 mg gel
Placebo (1.5 ml)Drug
BZ371A-matched placebo
Placebo (1.0 ml)Drug
BZ371A-matched placebo
Placebo (0.5 ml)Drug
BZ371A-matched placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Efficacy in increasing arousalTime frame: Baseline, 4 weeks and 8 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Centro de Pesquisa Clínica Multiusuário (CePeM)
Rio de Janeiro, Rio de Janeiro, Brazil · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.